Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Lowering the dose of ziprasidone can cause sudden restlessness and urge to move in patients.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Polynucleotide injections improved eye wrinkles with few side effects.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Injection contraception has more negative side effects than hormonal pills.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

PRP injections may be an effective treatment for severe hair loss.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Two patients with stubborn hair loss grew hair after PDRN injections.

A new gene mutation causes insulin resistance in a girl and her mother.